SIRT1 and B-cell chronic lymphocytic leukemia: In addition, a recent work showed that treatment of chronic lymphocytic leukemia cells with nicotinamide blocks the deacetylating activity of endogenous SIRT1 leading to an inhibition of proliferation and to the activation of apoptosis.